skip to content
Dovepress - Open Access to Scientific and Medical Research
View our mobile site

8830

A guide to interpretation of neuroimmunological biomarkers in the combined antiretroviral therapy-era of HIV central nervous system disease

Review

(1391) Views  (761) Full article downloads

Authors: Katrina A Morris, Nicholas WS Davies, Bruce J Brew

Published Date August 2010 Volume 2010:2 Pages 59 - 72
DOI: http://dx.doi.org/10.2147/NBHIV.S7167

Katrina A Morris, Nicholas WS Davies, Bruce J Brew
Department of Neurology, St. Vincent’s Hospital, Sydney, Australia and St. Vincent’s Centre for Applied Medical Research, Sydney, New South Wales, Australia
Abstract: Biomarkers have emerging roles in diagnosis, prognostication, and treatment monitoring in patients with human immunodeficiency virus-related central nervous system disease. Currently, it is unlikely that a single biomarker will be able to fulfill these roles; rather a combination is more likely. In this review, we use a pathogenetic framework to discuss biomarkers derived from both the blood and cerebrospinal fluid. Emphasis is given to those biomarkers that have a more solid evidence base and those that are easily measurable.
Keywords: CSF, biomarker, HAND, HIV, CART







Readers of this article also read:

Role of aliskiren in cardio-renal protection and use in hypertensives with multiple risk factors
Variable cognitive benefits in HAART-treated patients: are aging and low cholesterol linked?
Amelioration of caspase 3,7 activity by SP01 in human primary neurons exposed to HIV
Relationships between the use of second-generation antipsychotics and changes in total cholesterol levels in children and adolescents perinatally infected with HIV
Cognitive function in treated HIV patients
Development of neurocognitive disorders in HIV/AIDS
Anti-HIV-1 drug toxicity and management strategies
A comparison of screening batteries in the detection of neurocognitive impairment in HIV-infected Spanish speakers
Immune activation and neuropsychiatric symptoms in human immunodeficiency virus type 1 infection
Emerging viral and bacterial infections of the central nervous system